Table 3.

Relative DD and FPD (%) Over Patient Flow Rate Range for Budesonide/Formoterol Easyhaler 320/9 μg/Inhalation and Symbicort Forte Turbuhaler

		Budesonide		Formoterol		Budesonide		Formoterol
Product	Flow*	DD	RSD	DD	RSD	FPD	RSD	FPD	RSD
Easyhaler developmental formulation	Min	98	9.3	98	10.9	93	1.1	91	2.9
	Median	100	8.4	100	9.1	100	0.4	100	1.1
	Max	98	9.6	99	7.7	102	4.4	105	4.1
Easyhaler final formulation	Min	98	8.1	98	8.9	89	7.2	90	6.8
	Median	100	8.0	100	8.7	100	3.0	100	1.3
	Max	103	9.4	102	9.7	102	5.1	101	4.1
Symbicort forte Turbuhaler	Min	87	13.8	88	13.8	86	10.2	86	10.5
	Median	100	18.9	100	18.8	100	8.5	100	8.5
	Max	97	14.2	97	14.5	100	8.9	101	8.9

^*Weighted PIF rates through the EH and TH inhalers achieved by the 10^th (min), 50^th (median), and 90^th (max) percentiles of asthmatic and COPD patients.